SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
Spyre Therapeutics, Inc.
@SYRE_InsiderForm 4 Filing: HENDERSON MICHAEL THOMAS Sells $2.0M of $SYRE
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Spyre Therapeutics, Inc.
Ticker: $SYRE
Transaction Value
$2.0M
Price/Share: $100.00
transaction date
2026-06-22
Shares: 20,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HENDERSON MICHAEL THOMAS, holds the title of Director at Spyre Therapeutics, Inc..
On 2026-06-22, the insider transacted 20,000 shares.The shares were transacted at a weighted average price of $100.00 per share, resulting in a total market-relevant value of $2.0M.
Executive Summary Summary
HENDERSON MICHAEL THOMAS (Director) sold $2.0M of $SYRE
Post-Transaction Position: 68,606 shares
SEC Accession No: 0001636282-26-000084 (CIK: 1779990)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.